Agreement between cerebrospinal fluid biomarkers, brain 18-Fluorodeoxyglucose PET, and clinical diagnosis in older adults with cognitive impairment

Agreement between cerebrospinal fluid biomarkers, brain 18-Fluorodeoxyglucose PET, and clinical diagnosis in older adults with cognitive impairment

Background: Clinical practice has advanced toward a combined diagnostic approach that involves clinical criteria and biological markers for Alzheimer’s disease (AD) and other dementias. Objective: To establish the level of diagnostic agreement between an initial clinical diagnosis and cerebrospinal...

Full description

Saved in:
Bibliographic Details
Main Authors: Alberto J. Mimenza-Alvarado, Karen G. León-del-Ángel, Rodrigo Hernández-Ramírez, Juan de D. Rodríguez-Callejas, Sara G. Yeverino-Castro, Sara G. Aguilar-Navarro
Format: Article
Language:English
Published: Permanyer 2024-01-01
Series:Revista de Investigación Clínica
Subjects:
18F-Fluorodeoxyglucose-positron emission tomography. Cerebrospinal fluid. Cognitive impairment. Dementia. Alzheimer’s disease. Brain aging.
Online Access:https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=513
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=513

Similar Items